OnCore Login

Return to Trial Database

LUN04-77

A Phase II Study of Erlotinib With Bevacizumab in Chemotherapy Naïve Performance Status (PS) 2 Patients With Advanced Non-Small Cell Lung Cancer

Status

Study Completed

Cancer Type(s)

Lung

Study Contact

Publications

Erlotinib and bevacizumab in chemotherapy naïve performance status 2 patients with advanced non-small-cell lung cancer
  • T Al Baghdadi, S Bhatia, W Harb, J Maher, J McClean, S Nattam, D Taber, M Yu, C Johnson N Hanna
Erlotinib and Bevacizumab in Newly Diagnosed Performance Status 2 or Elderly Patients With Nonsquamous Non-Small-Cell Lung Cancer, a Phase II Study
  • H Riggs, SI Jalal, TA Baghdadi, S Bhatia, J McClean , C Johnson, M Yu, D Taber, W Harb, N Hanna

Trial Locations

All sites in which the trial LUN04-77 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278